Glucagon-like peptide-1 receptor agonists (GLP-1RAs) like semaglutide are highly effective in treating obesity, but up to 45% of the resulting weight loss may be muscle, which has led to opportunities for product formulators to protect muscle mass
Typical features include depletion of commensals such as Lachnospiraceae and Ruminococcaceae , together with enrichment of potentially pathogenic taxa, including Enterobacteriaceae , Enterococcaceae , and Streptococcaceae [306, 307]
Speak to your health care provider before stopping GLP1-RAs to discuss when to stop and how to manage your condition
Hanashima C, Namiki H
Side effects: While generally safe, mild side effects like headaches, nausea, or flushing can occasionally occur
PINK1 is degraded through the N-end rule pathway